Functional studies of E7 proteins from different HPV types
- PMID: 8058327
Functional studies of E7 proteins from different HPV types
Abstract
We have performed comparative studies on the E7 proteins from malignant and non-malignant Human Papillomavirus types HPV 1, 6, 11, 16, 18, 33). GST/E7 fusion proteins from all these HPV types associate with Rb1, p107 and the cyclin A/CDK2 complex. As has been shown for Rb1, the association with p107 and Cyclin A was weaker for the 'low risk' HPV6 and 11 E7 proteins as compared to 'high risk' HPV16, 18 and 33 E7 proteins. In contrast the E7 protein of the benign type HPV1 bound Rb1, p107 and cyclin A with the same affinity as the 'high risk' E7 proteins. The affinities of the E7/Rb1 interaction have been confirmed in vivo by the 'two hybrid' method in the yeast Saccharomyces cerevisiae. Although HPV1 E7 showed the same affinity in vitro and in vivo for Rb1 as the high risk HPV E7s, it did not have the ability to activate the E2F-1 transcription factor inhibited by Rb1, nor did it have any transforming activity when coexpressed with activated ras in primary rodent cells.
Similar articles
-
The relative ability of human papillomavirus type 6 and human papillomavirus type 16 E7 proteins to transactivate E2F-responsive elements is promoter- and cell-dependent.Virology. 1997 Dec 8;239(1):238-46. doi: 10.1006/viro.1997.8885. Virology. 1997. PMID: 9426463
-
Binding of the human E2F transcription factor to the retinoblastoma protein but not to cyclin A is abolished in HPV-16-immortalized cells.Oncogene. 1992 Sep;7(9):1681-6. Oncogene. 1992. PMID: 1323816
-
Human papillomavirus E7 proteins stimulate proliferation independently of their ability to associate with retinoblastoma protein.Oncogene. 2000 Feb 10;19(6):821-6. doi: 10.1038/sj.onc.1203375. Oncogene. 2000. PMID: 10698500
-
Retrovirus-mediated delivery of HPV16 E7 antisense RNA inhibited tumorigenicity of CaSki cells.Gynecol Oncol. 2000 Sep;78(3 Pt 1):293-301. doi: 10.1006/gyno.2000.5916. Gynecol Oncol. 2000. PMID: 10985883
-
Transforming proteins of the papillomaviruses.Intervirology. 1994;37(3-4):168-79. doi: 10.1159/000150375. Intervirology. 1994. PMID: 7843928 Review. No abstract available.
Cited by
-
The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation.Proc Natl Acad Sci U S A. 2006 Jan 10;103(2):437-42. doi: 10.1073/pnas.0510012103. Epub 2005 Dec 28. Proc Natl Acad Sci U S A. 2006. PMID: 16381817 Free PMC article.
-
The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2.Genes Dev. 1997 Aug 15;11(16):2101-11. doi: 10.1101/gad.11.16.2101. Genes Dev. 1997. PMID: 9284049 Free PMC article.
-
The association of mammalian DREAM complex and HPV16 E7 proteins.Am J Cancer Res. 2015 Nov 15;5(12):3525-33. eCollection 2015. Am J Cancer Res. 2015. PMID: 26885443 Free PMC article. Review.
-
PTPN14 degradation by high-risk human papillomavirus E7 limits keratinocyte differentiation and contributes to HPV-mediated oncogenesis.Proc Natl Acad Sci U S A. 2019 Apr 2;116(14):7033-7042. doi: 10.1073/pnas.1819534116. Epub 2019 Mar 20. Proc Natl Acad Sci U S A. 2019. PMID: 30894485 Free PMC article.
-
ZER1 Contributes to the Carcinogenic Activity of High-Risk HPV E7 Proteins.mBio. 2022 Dec 20;13(6):e0203322. doi: 10.1128/mbio.02033-22. Epub 2022 Nov 8. mBio. 2022. PMID: 36346242 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous